HEALTH● LOW1h ago · Sep 8, 2026, 12:03 PM
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
CNBC · global
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH13m ago5,000 More Healthworkers Needed To Tackle Ebola In DRC— WHOChannels TVHEALTH26m ago'Be kind with yourself': US expat Robin Allison Davis on surviving cancer in ParisFrance 24 [en]HEALTH47m agoUCL: McTominay to miss Arsenal clash after heart procedureVanguard NigeriaHEALTH56m agoBreakfast at noon? Turns out weekend meals at random times can hurt men’s heartsEuroNews [en]